A detailed history of Profund Advisors LLC transactions in Novavax Inc stock. As of the latest transaction made, Profund Advisors LLC holds 73,968 shares of NVAX stock, worth $629,467. This represents 0.04% of its overall portfolio holdings.

Number of Shares
73,968
Previous 49,313 50.0%
Holding current value
$629,467
Previous $624,000 49.68%
% of portfolio
0.04%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$10.71 - $17.11 $264,055 - $421,847
24,655 Added 50.0%
73,968 $934,000
Q2 2024

Aug 13, 2024

SELL
$3.89 - $20.97 $808,128 - $4.36 Million
-207,745 Reduced 80.82%
49,313 $624,000
Q1 2024

May 08, 2024

BUY
$3.76 - $6.02 $1,530 - $2,450
407 Added 0.16%
257,058 $1.23 Million
Q4 2023

Feb 14, 2024

BUY
$4.8 - $7.67 $440,913 - $704,543
91,857 Added 55.74%
256,651 $1.23 Million
Q3 2023

Nov 13, 2023

SELL
$6.81 - $9.74 $234,189 - $334,948
-34,389 Reduced 17.27%
164,794 $1.19 Million
Q2 2023

Aug 10, 2023

BUY
$6.67 - $9.52 $63,645 - $90,839
9,542 Added 5.03%
199,183 $1.48 Million
Q1 2023

May 11, 2023

BUY
$5.76 - $12.48 $1.09 Million - $2.37 Million
189,641 New
189,641 $1.31 Million
Q2 2022

Aug 01, 2022

SELL
$36.28 - $75.29 $17,813 - $36,967
-491 Reduced 5.21%
8,928 $459,000
Q1 2022

May 10, 2022

SELL
$69.73 - $142.9 $68,126 - $139,613
-977 Reduced 9.4%
9,419 $694,000
Q4 2021

Feb 08, 2022

SELL
$134.56 - $217.97 $226,329 - $366,625
-1,682 Reduced 13.93%
10,396 $1.49 Million
Q3 2021

Nov 12, 2021

BUY
$177.8 - $270.58 $78,943 - $120,137
444 Added 3.82%
12,078 $2.5 Million
Q2 2021

Aug 12, 2021

SELL
$121.0 - $257.67 $268,620 - $572,027
-2,220 Reduced 16.02%
11,634 $2.47 Million
Q1 2021

May 14, 2021

BUY
$112.98 - $319.93 $68,578 - $194,197
607 Added 4.58%
13,854 $2.51 Million
Q4 2020

Feb 09, 2021

BUY
$78.74 - $139.5 $131,574 - $233,104
1,671 Added 14.44%
13,247 $1.48 Million
Q3 2020

Nov 13, 2020

BUY
$79.44 - $178.51 $919,597 - $2.07 Million
11,576 New
11,576 $1.25 Million

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $666M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.